The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2019 | Hematology in focus: MGUS with clinical significance
Joan Bladé
• 14 Jun 2019
Joan Bladé, MD, Hospital Clinic, Barcelona, Spain, discusses monoclonal gammopathy of unknown significance (MGUS), and the diseases associated with the condition at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
